Form 4: Tenon Medical Director Converts RSUs to Shares

Tenon Medical, Inc. Director Robert K. Weigle converted restricted stock units into common stock, increasing his direct beneficial ownership.

Summary

• Director Robert K. Weigle converted 78 restricted stock units (RSUs) into 78 shares of Tenon Medical, Inc. common stock on May 22, 2024.
• This conversion was part of RSUs granted on May 12, 2022, with the number of shares adjusted for two reverse stock splits (1-for-10 on November 2, 2023, and 1-for-8 on September 6, 2024).
• Following this transaction, Mr. Weigle directly beneficially owns 155 shares of common stock and retains 78 restricted stock units.
• The remaining 78 restricted stock units are scheduled for conversion into common stock on May 22, 2025, which will result in a total of 233 shares of common stock beneficially owned after that future transaction.

Sentiment

Score: 5

Explanation: Neutral. This is a routine disclosure of an insider converting restricted stock units into common stock, which is a standard compensation event and does not inherently indicate positive or negative company performance or outlook.

Positives

• Director Robert K. Weigle increased his direct beneficial ownership of Tenon Medical, Inc. common stock by 78 shares through RSU conversion.
• The conversion of RSUs into common stock aligns the director's interests more closely with shareholders.

Future Outlook

The filing indicates a future conversion of the remaining 78 restricted stock units into common stock on May 22, 2025, which will bring the director's total direct beneficial ownership to 233 shares.

Industry Context

This is a routine insider ownership disclosure, common across all publicly traded companies, and does not provide specific industry context or trends.

Related Party Transactions

• Conversion of restricted stock units (RSUs) granted to Director Robert K. Weigle into common stock.

Stakeholder Impact

• Shareholders: Minor impact as it's a routine conversion of compensation, slightly increasing the director's direct stake.
• Employees, Customers, Suppliers, Creditors: No direct impact from this filing.

Next Steps

• Conversion of the remaining 78 restricted stock units into common stock on May 22, 2025.

Key Dates

Keywords

Tenon Medical, TNON, Form 4, SEC filing, insider trading, beneficial ownership, restricted stock units, RSU conversion, director, common stock